Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
February 2, 2026
Approximately 5 minutes
Regulatory Requirements for Class I Medical Device Manufacturers in Belgium
Regulatory Requirements for Class I Medical Device Manufacturers in Belgium
1. General Obligations
Class I medical devices are the lowest risk class and generally do not require notified body intervention for CE marking. However, subcategories sterile (Is), measuring (Im), and reusable surgical instruments (Ir) require limited notified body assessment for specific aspects such as sterility, measurement function, or reprocessing. Manufacturers bear full responsibility for compliance with Regulation (EU) 2017/745 (MDR), effective since 26 May 2021. They must issue an EU Declaration of Conformity (Article 19 MDR) and fulfil general obligations under Article 10 MDR, including maintaining complete technical documentation. Non-EU manufacturers must appoint an EU authorised representative. Source: FAMHP Class I Medical Devices Page https://www.famhp.be/en/human_use/health_products/medical_devices_and_their_accessories/manufacturers/class_i_medical
2. Registration in Eudamed
Manufacturers must register in the Actors module of Eudamed. Registration is voluntary until 28 May 2026 and mandatory thereafter (Decision (EU) 2025/2371). After obtaining a Single Registration Number (SRN), complete registration via the FAMHP web portal, specifying device risk classes and establishment units. Source: FAMHP Class I Medical Devices Page https://www.famhp.be/en/human_use/health_products/medical_devices_and_their_accessories/manufacturers/class_i_medical
3. Device Registration and Notification
Class I devices must be registered in Eudamed's Devices module (voluntary until 28 May 2026, mandatory thereafter). During transition, Belgian manufacturers or authorised representatives must notify FAMHP no later than the day of placing on the market, using dedicated forms sent to notifications.meddev@fagg-afmps.be. From 28 May 2026, only Eudamed registration applies, and national notifications cease. Source: FAMHP Class I Medical Devices Page https://www.famhp.be/en/human_use/health_products/medical_devices_and_their_accessories/manufacturers/class_i_medical
4. Subcategories Requiring Notified Body Involvement
For Class Is (sterile), Im (measuring), and Ir (reusable surgical instruments), a notified body assesses the relevant aspects (sterility, measurement, or reprocessing). Standard Class I devices do not require notified body intervention. Source: FAMHP Class I Medical Devices Page https://www.famhp.be/en/human_use/health_products/medical_devices_and_their_accessories/manufacturers/class_i_medical
5. Post-Market Surveillance and Vigilance
During transition for devices under Directive 93/42/EEC, only MDR requirements for post-market surveillance, vigilance, and registration apply (Article 120(3) MDR; MDCG 2021-25). Source: FAMHP Class I Medical Devices Page https://www.famhp.be/en/human_use/health_products/medical_devices_and_their_accessories/manufacturers/class_i_medical
6. Notification of Changes
Significant changes must be notified to FAMHP within 15 days using the notification form. Transition from MDD to MDR notification is treated as a new notification. Source: FAMHP Class I Medical Devices Page https://www.famhp.be/en/human_use/health_products/medical_devices_and_their_accessories/manufacturers/class_i_medical
7. Transitional Provisions
Certain MDD-compliant Class I devices benefit from transitional arrangements under Article 120(3) MDR, allowing continued placement on the market with only specified MDR requirements applied. Source: FAMHP Class I Medical Devices Page https://www.famhp.be/en/human_use/health_products/medical_devices_and_their_accessories/manufacturers/class_i_medical
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Regulatory Requirements for Systems and Procedure Packs in Belgium
In Belgium, producers of systems and procedure packs under MDR (EU) 2017/745 must ensure compatibility of combined CE-marked devices, draw up a declaration, register in Eudamed (currently voluntary), and notify FAMHP during the transitional period using dedicated forms, with specific rules for changes and acknowledgements.
Approximately 5 minutes
Overview of In Vitro Diagnostic Medical Devices Regulation in Belgium
The FAMHP oversees in vitro diagnostic medical devices (IVDs) in Belgium under Regulation (EU) 2017/746 (IVDR), applicable since 26 May 2022, with transitional provisions from Directive 98/79/EC and phased Eudamed registration requirements until mandatory in 2026.
Approximately 5 minutes
Application Procedure for Free Sales Certificates in Belgium
In Belgium, Free Sales Certificates (FSCs) for medical devices and IVDs are issued by FAMHP electronically since February 2025, with applications submitted by email using specific forms, a fee of €283.66 per certificate in 2026, limits on devices per certificate, and required supporting documents including conformity declarations and transitional proofs where applicable.
Approximately 5 minutes
Procedure for Requesting Exceptional Use of Non-CE Marked Medical Devices in Belgium
In Belgium, FAMHP authorizes exceptional use of non-CE marked medical devices or IVDs under MDR Article 59 or IVDR Article 54 when justified by public health or patient safety needs, with no suitable alternatives available and significant expected benefit, via compassionate use for individual patients or national derogation.